KACI JACKSON: Open Payments
NPI 1144405937 · TULSA, OK. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$791 in 34 payments from 11 companies in 2025. Trend: 2023 $701 · 2024 $2,032 · 2025 $791
Food & beverage: $791
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 12 | $192 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 3 | $160 |
| Kestra Medical Technology Services, Inc. | 1 | $106 |
| Alnylam Pharmaceuticals Inc. | 5 | $105 |
| Merck Sharp & Dohme LLC | 4 | $62 |
| E.R. Squibb & Sons, L.L.C. | 2 | $42 |
| Novo Nordisk Inc | 2 | $40 |
| AngioDynamics, Inc. | 2 | $39 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $16 |
| Abbott Laboratories | 1 | $14 |
Products named: LEQVIO, LifeVest, Assure WCD, ONPATTRO, AMVUTTRA, VERQUVO, ELIQUIS, Wegovy.
Industry payments across OK — which companies pay providers there.
